Treatment-induced adaptive immunosuppression in EGFR-mutant lung cancer
Bidragets beskrivning
In this project, we will investigate how targeted therapy in lung cancer influence the tumor immune response. Cancer cells that change during treatment may affect the tumor immune response. This could have a significant impact on treatment efficacy and the development of resistance. The project utilizes new mouse models and advanced single-cell techniques to comprehensively investigate the targeted therapy -induced changes in the tumor immune response in lung cancer, and to understand in detail the role of treatment-altered cancer cells in regulating the immune response. Our ultimate goal is to develop and test new ways to treat lung cancer.
Visa merStartår
2025
Slutår
2029
Beviljade finansiering
Finansiär
Finlands Akademi
Typ av finansiering
Akademiprojekt
Utlysning
Beslutfattare
Forskningsrådet för biovetenskap, hälsa och miljö
16.06.2025
16.06.2025
Övriga uppgifter
Finansieringsbeslutets nummer
370023
Vetenskapsområden
Biomedicinska vetenskaper
Forskningsområden
Biolääketieteet